Pipette Market: By Product Type (Electronic Pipette, Manual Pipette), By Channel (Single Channel, Multi-Channel), By Volume (<0.1 µL, 0.1-20 µL, 20-300 µL, 300-500 µL, 500-1000 µL, >1000 µL), By End User (Hospitals, Food & Beverages Laboratories, Pharmaceutical and Biotechnology Companies, Academic and Research Institute, Others), and Geography    

Pipette Market was valued at USD 1,289.2 million in 2023 and is poised to grow at a CAGR of 4.2% from 2024 to 2030. The pipette market is driven by several factors increasing demand for research and development activities in the pharmaceutical and biotechnology sectors, pipettes are essential tools for accurate and precise liquid handling in these industries, which are witnessing significant growth due to rising investments in drug discovery, development, and diagnostics. Growing focus on personalized medicine, personalized medicine requires the handling of small volumes of liquids, which is driving the demand for electronic pipettes that offer greater accuracy and precision.

Rising government funding for research in areas such as genomics, proteomics, and cell biology is propelling the demand for pipettes. Pipettes play a crucial role in minimizing the risk of contamination in laboratories, which is a major concern for researchers. However, the constraints of the pipette market hinder the growth with some factors such as the high initial cost of electronic pipettes, and stringent regulations governing the use of pipettes. Electronic pipettes offer superior performance compared to manual pipettes, but their higher cost can be a deterrent for some laboratories, especially in resource-constrained settings. Pipettes are classified as medical devices in some regions, which subjects them to strict regulatory requirements. This can increase the cost and complexity of bringing new pipettes to market.

Pipette Market Key Developments:

• In December 2020, Corning received a $15 million award from the U.S. Department of Defense (DoD), in coordination with the Department of Health and Human Services (HHS), for the domestic production of robotic pipette tips used in support of diagnostic testing for COVID-19.
• In September 2021, Thermo Fisher Scientific secured a $192.5 million contract from the U.S. Department of Defense to expand domestic production of pipette tips.